These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1278735)

  • 1. Proceedings: A controlled trial of H2-receptor antagonists in prophylaxis of bleeding from gastrointestinal erosions in fulminant hepatic failure.
    Bailey RJ; Macdougall BR; Williams R
    Gut; 1976 May; 17(5):389. PubMed ID: 1278735
    [No Abstract]   [Full Text] [Related]  

  • 2. H2-receptor antagonist in the prevention of acute upper gastrointestinal hemorrhage in fulminant hepatic failure: a controlled trial.
    MacDougall BR; Williams R
    Gastroenterology; 1978 Feb; 74(2 Pt 2):464-5. PubMed ID: 304430
    [No Abstract]   [Full Text] [Related]  

  • 3. Metiamide therapy of bleeding peptic ulcer during chronic hemodialysis.
    Kruss DM; Ilangovan S
    Am J Dig Dis; 1977 Jul; 22(7):662-3. PubMed ID: 879135
    [No Abstract]   [Full Text] [Related]  

  • 4. H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials.
    Macdougall BR; Bailey RJ; Williams R
    Lancet; 1977 Mar; 1(8012):617-9. PubMed ID: 66425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of stress-induced upper gastrointestinal/hemorrhage with metiamide.
    MacDonald AS; Steele BJ; Bottomley MG
    Lancet; 1976 Jan; 1(7950):68-70. PubMed ID: 54585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Reversal of metiamide-induced agranulocytosis during treatment with cimetidine.
    Burland WL; Sharpe PC; Colin-Jones DG; Turnbull PR; Bowskill P
    Lancet; 1975 Nov; 2(7944):1085. PubMed ID: 53565
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience with metiamide.
    Haggie SJ; Clark CG; Black JW; Wyllie JH
    Fed Proc; 1976 Jun; 35(8):1948-52. PubMed ID: 1269779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: The effect of the histamine H2-receptor on canine gastric mucosal barrier.
    Kenyon G; Carter DC
    Gut; 1976 May; 17(5):388. PubMed ID: 1278733
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: Should peptic ulcer treatment relieve symptoms or heal ulcers?
    Thompson MH; Venables CW
    Gut; 1976 May; 17(5):397. PubMed ID: 58807
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug therapy and prevention of acute upper gastrointestinal hemorrhage].
    Londong W
    Z Gastroenterol; 1983 Jun; 21(6):282-9. PubMed ID: 6137116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current concepts in drug therapy. No. 17. Histamine H2 - receptor antagonists.
    Lionel ND
    Ceylon Med J; 1975 Jun; 20(2):124. PubMed ID: 239793
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of stress ulcer hemorrhage with H2-receptor blockade].
    Dammann HG; Müller P; Flasshoff D; Simon B
    Med Klin Prax; 1982 Feb; 77(4):54-5. PubMed ID: 6123068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?
    Geus WP
    Scand J Gastroenterol Suppl; 2000; (232):10-20. PubMed ID: 11232484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: The prevention of relapse in duodenal ulceration by long-term nocturnal metiamide treatment.
    Thompson MH; Venables CW
    Gut; 1976 May; 17(5):389. PubMed ID: 819332
    [No Abstract]   [Full Text] [Related]  

  • 15. [H2-antihistaminics, III: Synthesis and H2-antihistaminic activity of sulfoxides and sulfones analogous to metiamide (author's transl)].
    Herke J; Schunack W
    Arch Pharm (Weinheim); 1979 Jan; 312(1):35-9. PubMed ID: 34376
    [No Abstract]   [Full Text] [Related]  

  • 16. Endoscopic appearances of hemorrhagic peptic ulcers and efficacy of H2-receptor antagonists.
    Fusamoto H; Kawano S; Tsuji S; Oshita M; Nagano K; Ohmae A; Sawaoka H; Nagai Y; Kasahara A; Sugimoto T; Kamada T
    Hepatogastroenterology; 1996; 43(7):169-73. PubMed ID: 8682457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the tumor inhibiting effects of three histamine H2-receptor antagonists.
    Tutton PJ; Barkla DH
    Anticancer Res; 1983; 3(1):7-10. PubMed ID: 6131640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [H2-antihistaminics, II: Synthesis and pharmacology of alpha-substituted metiamide analogues (author's transl)].
    Wegner K; Fritschi E; Schunack W
    Arch Pharm (Weinheim); 1978 Feb; 311(2):98-103. PubMed ID: 25641
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term treatment of systemic mastocytosis with histamine H2 receptor antagonists.
    Johnson GJ; Silvis SE; Roitman B; Blumenthal M; Gilbert HS
    Am J Gastroenterol; 1980 Dec; 74(6):485-9. PubMed ID: 6782861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early clinical experience with metiamide, a histamine H2-receptor antagonist, in patients with duodenal ulcer.
    Thompson MH; Reed JD; Dale G; Venables CW
    Am J Dig Dis; 1975 Dec; 20(12):1135-41. PubMed ID: 1106188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.